SCHEMBL1406162

SCHEMBL1406162

COc1cc2oc(=O)c(C(=O)O)cc2cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 11/20 0.60
CA12 O43570 5/20 0.59
CA1 P00915 5/20 0.59
CA6 P23280 5/20 0.59
CA7 P43166 5/20 0.59
CA9 Q16790 5/20 0.59
CA14 Q9ULX7 5/20 0.59
CA5B Q9Y2D0 5/20 0.59
CA5A P35218 4/20 0.59
CA2 P00918 4/20 0.59
CA3 P07451 4/20 0.59
KDM4E B2RXH2 2/20 0.59
ALDH1A1 P00352 2/20 0.59
SLC16A3 O15427 2/20 0.59
HPGD P15428 2/20 0.59
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CA4 P22748 4/20 0.55
MAOB P27338 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13740054 0.88 CA12 (0.66) GPR35CA12CA1CA6CA7
SCHEMBL25696504 0.84 CA12 (0.61) GPR35CA12CA1CA6CA7
SCHEMBL25697015 0.84 CA12 (0.61) GPR35CA12CA1CA6CA7
SCHEMBL27866083 0.82 GPR35 (0.70) GPR35CA12CA1CA6CA7
SCHEMBL1406281 0.82 GPR35 (0.67) GPR35CA12CA1CA6CA7
SCHEMBL25209186 0.82 GPR35 (0.60) GPR35CA12CA1CA6CA7
SCHEMBL30425364 0.82 GPR35 (0.60) GPR35CA12CA1CA6CA7
SCHEMBL1406460 0.81 GPR35 (0.58) GPR35CA12CA1CA6CA7
SCHEMBL530997 0.80 TSHR (0.48) GPR35CA12CA1CA6CA7
SCHEMBL11278711 0.80 PIM1 (0.50) KDM4EALDH1A1HPGDL3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295053-B1 Novel 2H-chromen-2-one-3-carboxamides for medical uses INST MATERIA MEDICA CAMS (CN) 2016-10-19 EP disclosed
US-8338401-B2 Coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-12-25 US disclosed
US-8338401-B2 Coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-12-25 US disclosed
EP-2295053-A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2011-03-16 EP disclosed
US-20060148834-A1 Novel coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2006-07-06 US disclosed
EP-1570846-A1 THE NOVEL COUMARIN-AMIDE DERIVATIVES AND ITS PREPARATION, SAID DRUG COMPOSITION AND ITS USE THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148834-A1 Novel coumarin-amide derivatives and its preparation, said drug composition and its use INSR, GLS, INSRR GPR35 3656/4885CA12 3153/4885CA1 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.